patient receptivity to 6-monthly luteinizing hormone releasing hormone (LHRH) agonist therapy

International expert opinion: luteinizing hormone gonadotropin-releasing hormone

Watch Professor Axel Merseburger's expert summary on patient receptivity to 6-monthly luteinizing hormone releasing hormone (LHRH) agonist therapy.

Language Icon English
duration 2:36
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300070
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

testosterone suppression and testing during androgen deprivation therapy

International expert opinion: androgen deprivation therapy

Watch Professor Axel Merseburger's expert summary on the importance of testosterone suppression and testing during treatment on androgen deprivation therapy.

Language Icon English
duration 3:09
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300069
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

Subscribe to Oncology